A method of treating breast cancer with androgen receptor antagonists

Details for Australian Patent Application No. 2004207492 (hide)

Owner GTX Inc.

Inventors Dalton, James T.; Miller, Duane D.; Veverka, Karen A.; Steiner, Mitchell S.

Agent Griffith Hack

Pub. Number AU-A-2004207492

PCT Pub. Number WO2004/066922

Priority 60/441,313 22.01.03 US

Filing date 20 January 2004

Wipo publication date 12 August 2004

International Classifications

A61K 031/66 - Phosphorus compounds

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/066922 Priority application(s): WO2004/066922

16 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004207493-Compositions and methods for improving recovery after general anesthesia

2004207483-Fluid injection apparatus having frame levers